The risk of cardiovascular toxicity, which occurs with nonselective NSAIDs and with coxibs, is particularly relevant to older patients, who are more likely to have cardiovascular risk factors (eg, a history of myocardial infarction (MI) or cerebrovascular or peripheral vascular disease).